Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Bullboard Post History

by pmrider


V.BTI

RE:Intrathecal vs. IV delivery to the CNS

2.5 stars

Should point out as well, that you will have more that crosses into the...

11 days ago

V.BTI

Intrathecal vs. IV delivery to the CNS

2.5 stars

Interesting discussion taking place.  There are some relevant articles that...

11 days ago

V.BTI

RE:RE:here's one to look at

5 stars

Sir Holler: "BTI has never shown us the efficacy of BT2111. Don't you think...

July 31, 2014

V.BTI

Shire & Armagen

4.5 stars

Not quite sure what Shire's motive is for this deal with Armagen.  The most...

July 24, 2014

V.BTI

TrancendPep - Implications

4.5 stars

On April 24th, biOasis came out with a PR with respect to our new...

July 14, 2014

V.BTI

Previous link didn't work. Try this

3.5 stars

Sorry, the link didn't work.  Try this process: http://www.aacr.org/home...

March 26, 2014

V.BTI

BT2111 Papers AACR Conference April 5-9

3.5 stars

Bioasis is presenting 3 papers at the AACR conference: http://www...

March 26, 2014

V.BTI

RE:RE:RE:RE:RE:Breaking through resistance $1.30 offer

4.5 stars

Outofthered: Of significance in the last NR, was the following statement...

March 6, 2014

V.BTI

Our Market & RMT

4.5 stars

Receptor Mediated Transcytosis technologies have been around for many years...

February 18, 2014

V.BTI

Roche & Scientific America Article

4.5 stars

Finally had the opportunity to have a "look under the hood" on Roche's brain...

January 15, 2014

V.BTI

RE:RE:Interesting Article on AstraZeneca/Medimmune

3 stars

Jekyl: You raise alot of interesting points and certainly the article is...

December 5, 2013

V.BTI

Interesting Article on AstraZeneca/Medimmune

5 stars

Here is a link to the article (apologize in advance if it has been discussed...

November 28, 2013

V.BTI

RE:AngioChem

3.5 stars

Hi BearDown: Over the years, there has been some debate over which receptor...

November 13, 2013

V.BTI

Initial take on the NR

3.5 stars

There is one point in the NR that about says it all: "Understanding the...

November 12, 2013

V.BTI

RE:Gazyva

3 stars

Kayaker: One would think that this would be something Roche would be...

November 1, 2013

V.BTI

Shire

3.5 stars

Shire has recently redone their website and included some interesting items...

October 22, 2013

V.BTI

RE:RE:Trastuzumab across the BBB

5 stars

Sniper: I think that Kayaker touched on the most important point - What else...

October 10, 2013

V.BTI

RE:preclinical deal

5 stars

For those of you that might think the quantity of NR's is directly...

August 26, 2013

V.BTI

RE:RE:to-BBB

0 stars

Sniper: I hope that tobbb is successful.  What this industry needs, is...

August 20, 2013

V.BTI

AstraZeneca Chief on Celltrion

1 star

Interesting commentary from Pascal Soriot on speculation of AZ acquiring...

August 12, 2013